Skip to main content

Table 5 Anthropometric, clinical and biochemical variables in both groups of hypertensive women before and after intervention; Porto Firme, MG, Brazil, 2009.

From: Non-pharmacological treatment of hypertension in primary health care: A comparative clinical trial of two education strategies in health and nutrition

  Group 1 (workshops) Group 2 (workshops + home orientation)
  Initial (T0) Final (T3) Z pa Initial (T0) Final (T3) Z pa
Weight, kg 75.3 ± 17.4 75.4 ± 16.3 -0.126 0.452 77.7 ± 14.2 76 ± 13.1 -2.098 0.018*
BMI, kg/m 2 31.3 ± 7 31.3 ± 6.3 -0.157 0.440 33.4 ± 5.7 32.7 ± 5.3 -2.062 0.019*
WC, cm 100.3 ± 14.9 98.5 ± 14.5 -2.100 0.017* 104 ± 12.2 99.7 ± 11.5 -2.986 0.001*
Systolic BP, mmHg 119.3 ± 14.9 117.4 ± 15.9 -0.637 0.261 129.3 ± 17 116.1 ± 9.6 -2.631 0.004*
Diastolic BP, mmHg 80.7 ± 10.7 77.1 ± 14.9 -0.962 0.168 78.4 ± 10.7 76.9 ± 7.5 -0.486 0.344
Glucose, mg/dL 110.9 ± 67.3 85.8 ± 14.6 -1.083 0.279 116.8 ± 35 97.8 ± 27.8 -2.552 0.011*
Triglycerides, mg/dL 172.1 ± 84.3 146.7 ± 71 -0.464 0.650 147.3 ± 72.8 131.3 ± 51.5 -0.804 0.421
Cholesterol total, mg/dL 220.8 ± 54.1 212.3 ± 52.8 -0.035 0.972 203.5 ± 56.2 193.3 ± 30.1 -0.393 0.695
LDL-cholesterol, mg/dL 136 ± 30.6 136.3 ± 42.9 -0.175 0.861 123.5 ± 48.6 117.4 ± 24.8 -0.175 0.861
HDL-cholesterol, mg/dL 42.2 ± 6.2 46.5 ± 13 0.877 0.381 50.9 ± 8.8 49.5 ± 9.3 -0.350 0.727
  1. Values in cells are mean ± standard deviation; a p-value for difference in values before and after intervention in Groups 1 and 2 by the Wilcoxon test; *p < 0.05.